Report: Patents On Water Technology On The Rise 20/12/2013 by Intellectual Property Watch 6 Comments A new private-sector report shows that after a downturn, patents on a range of technologies for water are back on the rise as companies are busy innovating around a basic human need and resource.
Swiss Group Finds Patent-Related Ethical Violations By Pharma Overseas 17/12/2013 by Intellectual Property Watch 1 Comment The Berne Declaration, a Swiss non-profit, has released results of investigations that found industry-sponsored offshore clinical drug trials in developing countries involve “multiple ethical violations,” a problem increased by the patent-based industry business model.
The EU-Thailand FTA: What Fate For Access To Medicines? 12/12/2013 by Intellectual Property Watch Leave a Comment Following the public outcry over the EU’s demands for stringent intellectual property rules that would dramatically raise medicines prices in India, you would expect the EU to think twice about making similar demands in future trade agreements, particularly with low- and middle-income countries. Yet, this is precisely what is going on now in the negotiations for a free trade agreement between the EU and Thailand, writes Tessel Mellema.
Medicines Patent Pool Strikes Deal With Bristol-Myers Squibb 12/12/2013 by Intellectual Property Watch Leave a Comment The Medicines Patent Pool today announced a new agreement with biopharmaceutical company Bristol-Myers Squibb for an HIV medicine, which is expected to increase access in 110 developing countries.
Concerns Raised To Global Fund Over Panel On Tiered Medicines Pricing 10/12/2013 by William New, Intellectual Property Watch 3 Comments CAPE TOWN, SOUTH AFRICA – Public groups this week urged Mark Dybul, head of the Geneva-based Global Fund for HIV, Tuberculosis and Malaria, to reconsider the establishment of a panel to look at tiered pricing for middle income countries, potentially allowing companies to charge them higher prices. And separately, activists reported on progress in South Africa’s HIV strategy.
IPRs An Issue In Latest HIV Treatment Monitoring Test, Group Says 10/12/2013 by William New, Intellectual Property Watch Leave a Comment CAPE TOWN, SOUTH AFRICA – Intellectual property rights represent a hurdle to lower-priced, high quality tests of HIV treatment monitoring in developing countries, public health group Médecins Sans Frontières (MSF, Doctors without Borders) said today.
Experts At WHO Select Eight Projects To Boost Medical R&D For Developing Countries 06/12/2013 by Catherine Saez, Intellectual Property Watch 2 Comments A group of experts summoned to select projects presenting innovative ways to foster research and development of medical products for diseases primarily affecting developing countries at the World Health Organization this week finished their work and selected eight projects out of 22. Civil society was quick to express concern that the selected projects do not propose a new way forward. Now WHO member states must narrow the list down further.
USTR Says Its TPP Proposal On IP And Public Health Shows Flexibility 28/11/2013 by William New, Intellectual Property Watch 2 Comments The Office of the United States Trade Representative (USTR) yesterday issued a statement on the status of the Trans-Pacific Partnership trade agreement talks on intellectual property rights and public health, suggesting that it has put forward new ideas on the issue. The statement is worded to reflect that USTR has heard the concerns of other governments and of public health advocates, but it’s unclear if those groups will accept it.
Medical R&D Projects Proposed By WHO Regions Show Diversity 26/11/2013 by Intellectual Property Watch Leave a Comment The regions of the World Health Organization earlier this month submitted their proposals for projects to boost research and development of health technologies for diseases disproportionately affecting developing countries and lacking a market incentive. A shortlist of projects will be selected by a group of WHO-chosen experts at a 3-5 December meeting in Geneva.
International Organisations, Industry, Launch Campaign Against Fake Medicines 26/11/2013 by William New, Intellectual Property Watch 1 Comment Ten global health organisations today launched “Fight the Fakes,” a global campaign against “fake” medicines, aimed at raising awareness about medicines – brand or generic – that are not what they claim to be. Meanwhile, a Swiss pharmaceutical company official was named head of investigations at a top international public health organisation.